2-(4'-tert-butyl-2',6'-dimethylphenylmethyl)imidazoline,
Amidrin,
Balkis,
Chlorohist-LA,
Decongest,
espa-rhin,
Gelonasal,
Idasal,
Idril N,
Imidin,
Nasan,
Nasengel AL,
NasenGel ratiopharm,
Nasenspray AL,
NasenSpray ratiopharm,
Nasentropfen AL,
NasenTropfen ratiopharm,
Novorin,
Otradrops,
Otraspray,
Otriven,
Otrivin,
Otrivin Mentol,
Rapako,
schnupfen endrine,
Snup,
stas,
xylometazoline,
xylometazoline hydrochloride,
xylometazoline monohydrochloride,
Xylometazoline hydrochloride,
1218-35-5,
Xylometazoline HCl,
2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline hydrochloride,
Xylometazoline (hydrochloride),
MFCD00238707,
MLS000069695,
UNII-X5S84033NZ,
SMR000058526,
DSSTox_CID_25223,
DSSTox_RID_80760,
DSSTox_GSID_45223,
Xylometazoline hydrochloride, 98%,
2-(4-tert-butyl-2,6-dimethylbenzyl)-4,5-dihydro-1h-imidazole hydrochloride,
2-[(4-tert-butyl-2,6-dimethyl-phenyl)methyl]-4,5-dihydro-1H-imidazole hydrochloride,
2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole hydrochloride,
1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, hydrochloride (1:1),
X5S84033NZ,
Xylometazoline hydrochloride (USP),
SR-01000000230,
NCGC00016101-02,
CAS-1218-35-5,
stas hydrochloride,
xylometazoline-hcl,
otrivinhydrochloride,
otrivinehydrochloride,
Prestwick_574,
AC1NQZZM,
2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole;hydrochloride,
Opera_ID_1744,
xylometazolin hydrochloride,
Neo-Synephrine II (TN),
SCHEMBL41837,
MLS001076518,
SPECTRUM1500614,
CHEMBL1256400,
DTXSID3045223,
CTK4B2768,
REGID_for_CID_5282386,
YGWFCQYETHJKNX-UHFFFAOYSA-N,
HMS1568N07,
HMS1921K09,
Pharmakon1600-01500614,
Xylometazoline Hydrochloride ,(S),
BCP22148,
HY-B0475,
Tox21_110305,
Tox21_501269,
ANW-41892,
CCG-39900,
NSC757378,
s2576,
AKOS015895456,
Tox21_110305_1,
AC-8301,
AN-8175,
API0006284,
CS-2589,
KS-5144,
LP01269,
NSC-757378,
NCGC00016101-10,
NCGC00094506-01,
NCGC00094506-02,
NCGC00094506-03,
NCGC00094506-04,
NCGC00094506-05,
NCGC00261954-01,
AK608063,
H812,
AB0013278,
AB1009546,
TR-003540,
EU-0101269,
FT-0603554,
SW196748-3,
D00757,
K-1647,
X 6000,
Xylometazoline hydrochloride, analytical standard,
218X355,
A804796,
I06-0599,
J-004686,
SR-01000000230-2,
SR-01000000230-7,
2-(4-tert-butyl-2,6-dimethylbenzyl)-2-imidazolinmonohydrochloride,
Xylometazoline hydrochloride, British Pharmacopoeia (BP) Reference Standard,
Xylometazoline hydrochloride, European Pharmacopoeia (EP) Reference Standard,
2-(4-(tert-butyl)-2,6-dimethylbenzyl)-4,5-dihydro-1H-imidazole hydrochloride,
2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-1h-imidazol,
Xylometazoline hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material,
Xylometazoline hydrochloride, United States Pharmacopeia (USP) Reference Standard,
Otrivine,
Rhinactin,
Olynth,
Neo-Synephrine II,
Otrivin hydrochloride,
Otrivine hydrochloride,
C16H25ClN2,
C16H24N2.ClH,
(R)-3-(Methylamino)pyrrolidine,
C16-H24-N2.Cl-H,
XYLOMETAZOLINEHYDROCHLORIDE,
Xylometazoline hydrochloride [USP],
EINECS 214-936-4,
CID5282386,
B2066,
X0063,
2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline monohydrochloride,
1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, monohydrochloride,
Xylometazoline hydrochloride, 98%, an alpha-adrenoceptor agonist - 1G 1g,
2-IMIDAZOLINE, 2-(4-tert-BUTYL-2,6-DIMETHYLBENZYL)-, MONOHYDROCHLORIDE,
1H-Imidazole, 2-((4-(1,1-dimethylethyl)-2,6-dimethylphenyl)methyl)-4,5-dihydro-, monohydrochloride,